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ABSTRACT OF THE THESIS
EXPOSURE-BASED COGNITIVE BEHAVIORAL TREATMENT FOR PHOBIC
AND ANXIETY DISORDERS: TREATMENT EFFECTS AND MAINTENANCE
FOR HISPANIC AMERICAN RELATIVE TO EURO-AMERICAN YOUTHS
by
Rebecca M. Fuentes
Florida International University, 2002
Miami, Florida
Professor Wendy K. Silverman, Major Professor
A total of 131 Hispanic American and Euro-American youths (ages 6 to 16 years)
who participated in previous clinical trials for phobic and anxiety disorders were
compared in terms of treatment gains and maintenance. In terms of treatment gains,
the findings indicated that Hispanic American and Euro-American youths responded
more similarly than differently to the exposure-based cognitive/behavioral treatments
from pre- to post-treatment. This was found using traditional hypotheses testing,
calculation of effect sizes, and statistical equivalence testing. In terms of treatment
maintenance, the findings also demonstrated that Hispanic American and Euro-
American youths responded more similarly than differently, albeit with some
variations within specific assessment points. The findings are discussed in terms of
the need to evaluate empirically supported treatments for use with ethnic minority
populations, particularly Hispanic Americans.
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CHAPTER I
INTRODUCTION
The 1990s witnessed a flurry of clinical trials aimed at developing and
evaluating psychosocial treatments for youths with phobic and anxiety disorders
(from hereon referred to as anxiety disorders). The treatments were downscaled
adaptations of treatments found to be efficacious with adults (e.g., Barlow, Craske,
Cerny, & Klosko, 1989; Barlow, Rapee, & Brown, 1992; Borkovec & Costello,
1993; Heimberg, Becker, Goldfinger, & Vermilyea, 1985), namely, exposure-based
cognitive behavior treatments. Thus, all the treatments evaluated in the childhood
anxiety disorders randomized clinical trials strongly emphasize youths' involvement
in graded exposures to anxiety provoking situations, objects, or images coupled with
behavioral (e.g., positive reinforcement) and cognitive procedures (e.g., self
evaluation and self reward), albeit with variations existing across some of the
treatments (e.g., degree of parental involvement, individual format, group format)
(see Silverman & Kurtines, 1996).
Table 1 presents a listing of the exposure-based cognitive behavior therapy
randomized clinical trials conducted with youths that have empirically demonstrated
that anxiety disorders can be significantly reduced via this type of psychosocial
intervention. Because of the consistent and positive evidence produced in these
trials, cognitive behavior therapy has been earmarked as an "empirically supported
treatment" for anxiety disorders in youth (American Psychological Association,
Division 12 Task Force on Psychological Interventions; Chambless & Hollon, 1998).
Similarly, in "Official Action" taken by the American Academy of Child and
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Adolescent Psychiatry (1997) regarding "practice parameters" for anxiety disorders
it was indicated, "pharmacotherapy should not be used as the sole intervention" (p.
755); rather, the types of procedures used in cognitive behavior therapy (e.g., graded
exposures, positive reinforcement, self evaluation) were recommended (American
Academy of Child and Adolescent Psychiatry, 1997).
Relevant to the present study are the rates of ethnic minority groups'
participation, particularly Hispanic Americans' participation, in the clinical trials
listed in Table 1. As the table shows, most of the trials included either no Hispanic
American participants or an extremely small proportion. This low Hispanic
American participation rate reflects, in part, the times during which the trials were
conducted. That is, prior to Kendall (1994) there existed no clinical trials evidence
that anxiety disorders in youths could even be successfully reduced. Thus, the
zeitgeist was such that it was deemed critical for researchers to either produce this
empirical evidence (e.g., Kendall, 1994) and/or replicate or extend the evidence (e.g.,
Barrett, Dadds, & Rapee, 1996: Kendall, Flannery-Schroeder, Panichelli-Mindel,
Southam-Gerow, Henin, & Warman, 1997).
Because the clinical trials' research activities during the 1990s were therefore
mainly directed at producing and/or replicating or extending empirical evidence,
researchers began by working with samples drawn from the population that were
most readily available, namely, the "mainstream" (i.e., Euro-American youths and
their families, United States Department of Health and Human Services, 1994). This
was viewed as a reasonable and practical way to proceed not just because of the
absence of empirical research evidence with the "mainstream," but also because little
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was known empirically about acculturation- and culture-specific issues relating to
treating ethnic minority youths, in general, and ethnic minority youths with anxiety
disorders, in particular.
As Table 1 also shows, the two trials conducted by Silverman and colleagues
(Silverman, Kurtines, Ginsburg, Weems, Lumpkin, & Carmichael, 1.999a; and
Silverman, Kurtines, Ginsburg, Weems, Rabian, & Serafini, 1999b) were exceptions
in terms of having sizable proportions of Hispanic American participants (37% and
46%, respectively). The higher rates of Hispanic American participation in the
Silverman et al. trials relative to the other trials is because Silverman et al. drew from
the population of Miami-Dade county, Florida, which has one of the largest
populations of Hispanic Americans in the U.S. (1.3 million, 57.3% of the total
county population).
Because the Silverman et al. (1999 a, b) clinical trials were conducted during
the same zeitgeist as the other trials listed in Table 1, the specific aims of these two
trials were similar to these others: to produce empirical evidence for overall
treatment efficacy. Thus, in Silverman et al. the overall positive findings from the
respective clinical trials were reported.
In the present study, post hoc comparisons across the two trials were
conducted to examine how the Hispanic American youths fared relative to the Euro-
American youths in terms of treatment outcome and maintenance. Specifically, this
study compared the two groups' diagnostic recovery rates, youth and parent
completed questionnaire scores, obtained effect sizes, and clinically significant
improvements in terms of normative comparisons on the Child Behavior Checklist
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(Achenbach, 1991). Because statistical non-significance does not imply equivalence,
in addition to "traditional" hypothesis tests (e.g., repeated measures analyses),
statistical equivalence tests (Jaccard & Guilamo-Ramos, 2002; Rogers, Howard, &
Vessey, 1993) were performed. Treatment maintenance of Hispanic American
relative to Euro-American participants also was examined in terms of youth and
parent completed questionnaire scores from pre- to posttreatment, 3-, 6-, and 12-
month follow-up using hierarchical linear modeling (Raundenbush, Bryk, Cheong, &
Congdon, 2001).
The examination of these issues in the present study is a response to calls for
data that speak to the issue of whether empirically supported treatments (in this case,
exposure based cognitive behavioral therapy for use with anxiety disorders in youth)
can be generalized for use with various segments of minority populations (Hohmann
& Parron, 1996; Rogler, Malgady, Constantino, & Blumenthal, 1987). That is, does
an empirically supported treatment "work" with a non-mainstream or a specific
ethnic minority group (or subgroup) as it does with the mainstream group (Lloyd et
al., 1987; Sue, 1999; United States Department of Health and Human Services,
1994)? Thus, the purpose of this study was to provide preliminary evidence that may
shed some light on a course of action for future research with minority populations
by evaluating the efficacy of exposure-based cognitive behavioral therapy for the
treatment of anxiety disorders in Hispanic American youth.
Investigating this issue with Hispanic American youths is of particular
importance given that Hispanic Americans are both the fastest growing and second
largest minority group in the U.S., with approximately 28.6 million people of
Hispanic origin living in this country (11.9% of the U.S. population)(U.S. Bureau of
the Census, 2000). Consequently, there is an increased demand for the exploration of
mental health issues in the Hispanic American community, particularly in terms of
treatments that are both empirically supported and culturally sensitive.
Further, examining the efficacy of treatment for Hispanic Americans relative
to Euro-Americans may provide preliminary evidence for determining whether
simply exporting empirically supported treatments, which have been demonstrated to
be efficacious with Euro-Americans, results in relatively similar psychosocial gains
for Hispanic Americans.
Finally, investigating this issue with Hispanic American youths with anxiety
disorders is of particular importance given that anxiety disorders are the most
prevalent psychiatric disorders in young people (about 4.1% to 9.2%) (e.g.,
Bernstein, Borchardt, & Perwein, 1996) and given that anxiety disorders do not
necessarily spontaneously remit (Flakierska-Prakin, Lindstroem, & Gillberg, 1997;
Last, Hansen, & Franco, 1998; Woodward & Fergusson, 2001).
As noted, the present evaluation of exposure-based cognitive behavioral
therapy is based on the samples that participated in two Silverman et al. (1999a and
b) clinical trials. The Hispanic Americans recruited and selected for participation in
Silverman et al. agreed to receive the assessment and intervention procedures largely
in English and they did not request receiving the procedures in Spanish. (No more
than 4% were referred for assessment and treatment in Spanish.) The Silverman et al.
samples are therefore likely to be highly representative of the Hispanic American
population in the United States (74% of Hispanic Americans rate their ability to
speak English as "very well" or "well"; Department of Commerce, 1990). Overall,
the findings reported in this study may be viewed as stepping-stones for future
treatment research aimed at reducing anxiety disorders in Hispanic American youths.
In the following sections, a summary of the research literature on the efficacy
of exposure-based cognitive behavioral therapy for the treatment of anxiety disorders
in children is provided as well as a brief summary of the literature regarding
treatment research with ethnic minority populations.
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CHAPTER 11
LITERATURE VIEW
Exposure-based Cognitive Behavioral Therapy
Exposure-based cognitive behavioral therapy has received empirical support in
several clinical trials using both waitlist control (e.g., Kendall, 1994; Kendall et al.,
1997; Silverman et al., 1999b) and active control conditions (Last et al., 1998;
Silverman et al., 1999a) in the treatment of anxious youths. Several other studies
have also demonstrated the efficacy of exposure-based cognitive behavioral therapy
in the treatment of anxious youths (e.g., Barret, 1998; Beidel, Turner, & Morris,
2000; Spence, Donovan, & Brechman-Toussaint, 2000). This section will review
these and other studies that have provided support for the use of exposure-based
cognitive behavioral therapy in the treatment of anxious youths.
Kendall (1994) conducted the first published randomized clinical trial of an
exposure-based cognitive behavioral therapy with anxious children in which 47 9- to
13-year-old children were randomly assigned to either a cognitive behavioral
treatment condition or a waitlist control condition. Results of the trial provided
support for the efficacy of the cognitive behavioral treatment condition: children who
received the cognitive behavioral treatment demonstrated significant improvement
from pre- to posttreatment across parent reports, self-reports, and behavioral
observations, and 64% of these children were diagnosis free at posttreatment.
Further, 1-year follow-up data demonstrated that treatment gains were maintained for
the children in the cognitive behavioral condition.
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In a second randomized clinical trial, Kendall et al. (1997) randomly assigned
94 9- to 13-year-old children with anxiety disorders to either a cognitive behavioral
treatment condition or to a waitlist control condition. This trial showed comparable
results to the first, with the cognitive behavioral treatment group demonstrating
significant improvements when compared to the waitlist control group. Specifically,
over 50% of the cognitive behavioral group was free of their primary diagnosis at
posttreatment. For those cases in which the primary diagnosis remained at
posttreatment, analyses showed significant reduction on severity scores (Kendall et
al., 1997). A significantly greater percentage of children in the cognitive behavioral
group were also found to have returned to within the normal range of scores on
several measure of psychopathology as compared to the waitlist control group, and
these treatment gains were again maintained at 1-year follow-up.
Barrett (1998) reported on a randomized clinical trial in which a cognitive
behavioral group family-based intervention for childhood anxiety disorders was
evaluated. A sample of 60 children, 7- to 14-years-old, were randomly assigned to
three treatment conditions: group cognitive behavioral therapy (GROUP-CBT),
group cognitive behavioral therapy plus family management (GROUP-FAM), and a
waitlist control condition (WL). Results indicated that children assigned to either
GROUP-CBT or GROUP-FAM showed significant improvement compared to the
children assigned to the WL condition. Specifically, 64.8% of the children across the
two treatment conditions no longer fulfilled diagnostic criteria for an anxiety
disorder at posttreatment as compared to 25.2% of children in the WL group.
Children in the GROUP-CBT and GROUP-FAM also showed significant
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improvements at posttreatment on both parent and self-report measures as compared
to the WL group. Further, at 12-month follow-up, 64.5% of children in the GROUP-
CBT and 84.8% of the children in the GROUP-FAM were diagnosis free (Barrett,
1998).
In a study by Last et al. (1998) the efficacy of an exposure-based cognitive
behavioral treatment was evaluated relative to an education support control condition
for the treatment of children with school phobia. Surprisingly, results demonstrated
that the cognitive behavioral condition and the educational support control condition
were equally effective at returning children to school and reducing their anxiety
symptoms. Further, treatment gains were maintained (or increased) in both groups at
a 4-week follow-up (Last et al., 1998).
Similar results were found in a randomized clinical trial performed by
Silverman et al. (1999a) in which 81 children with phobic disorders were randomly
assigned to an exposure-based contingency management treatment condition (CM),
an exposure-based cognitive self-control treatment condition (SC), or an education
support control condition (ES). Children in both the CM and SC conditions showed
substantial improvement on all outcome measures, and these gains were maintained
at 3-, 6-, and 12-month follow-ups (Silverman et al., 1999a). Again, surprisingly,
children in the ES condition also showed substantial improvement at posttreatment
and at 3-, 6-, and 12-month follow-ups. Although the Last et al. (1998) and
Silverman et al. (1999a) studies do not demonstrate the superiority of an exposure-
based cognitive behavioral treatment for the treatment of phobic disorders in
children, they do provide further evidence for the effectiveness of this type of
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treatment for anxiety disorders. Interestingly, these two studies also demonstrated the
efficacy of educational support conditions for children with phobic disorders.
In another randomized clinical trial using the same clinic patient flow,
Silverman et al. (1999b), the efficacy of group cognitive-behavioral therapy (GCBT)
versus a wait-list control condition (WLC) for treating anxiety disorders in children
was evaluated. Results indicated that 64% of the children in GCBT no longer met
diagnosis for an anxiety disorder at posttreatment compared to 13% of the children in
the wait-list control condition. Further, children in GCBT showed substantial
improvement on all the main outcome measures, and maintained these treatment
gains at 3-, 6-, and 12-month follow-ups. Children in WLC did not show
improvement from the pre- to the postwait assessment point (Silverman et al,
1999b).
Beidel et al. (2000) randomly assigned 67 children (ages 8 and 12) with social
phobia to either a behavioral treatment condition (Social Effectiveness Therapy for
Children, SET-C) or an active control condition (Testbusters). Children in the SET-C
condition, which included social skills training and exposure to feared situations,
demonstrated significant improvement across several domains of functioning (i.e.,
reduction in social phobic fears, improvement in social skills and performance). At
posttreatment, 67% of the children in the SET-C condition no longer met diagnostic
criteria for social phobia compared to only 5% of the children in the Testbusters
condition. Further, treatment gains were maintained at 6-month follow-ip (Beidel et
al., 2000).
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In a randomized clinical trial performed by Flannery-Schroeder & Kendall
(2000), 37 children (8- to 14-years old) with anxiety disorders were randomly
assigned to a cognitive-behavioral individual treatment (ICBT), a cognitive-
behavioral group treatment (GCBT), or a wait-list control (WL). At posttreatment, a
substantially larger percentage of children in the treatment groups (73% individual,
50% group) did not meet diagnostic criteria for their primary anxiety disorder
compared to 8% of the children in the WL group. Further, significant improvements
were found in multiple child- and parent-reports of anxious distress and coping for
both ICBT and GCBT relative to the WL control condition (Flannery-Schroeder &
Kendall, 2000).
Lastly, Spence et al. (2000) randomly assigned 50 children (7- to 14-years old)
with social phobia to child-focused cognitive-behavioral therapy (CBT) or to a wait-
list control (WLC). Children in the CBT condition demonstrated significant
reduction in social and general anxiety throughout the treatment, and a significant
reduction occurred in the percentage of children in the treatment condition diagnostic
criteria for social phobia at posttreatment. Such improvements were not evident for
the WLC children, who showed minimal change during the treatment period (Spence
et al., 2000). Further, treatment effect for children in the CBT condition were
generally maintained at 12-month follow-up.
In summary, there is a growing body of literature that supports the efficacy of
exposure-based cognitive behavioral treatments for children with anxiety disorders
(e.g., Kendall, 1994; Barrett, 1998; Silverman et al., 1999b; Spence et al., 2000). No
study, however, has systematically examined the effectiveness of exposure-based
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cognitive behavioral therapy for Hispanic American youths relative to Euro-
American youths. Using the data from Silverman et al. 1999a & 1999b, this study
aims to shed light on the question of whether an empirically supported treatment
(i.e., exposure-based cognitive behavioral therapy) is effective for use with ethnic
minority groups, specifically Hispanic American youths.
Empirically Supported Treatments and Ethnic Minority Groups
Examining whether empirically supported treatments are effective for use with
ethnic minority population is of considerable importance in the backdrop of recent
calls in the literature for investigators to address the issue of ethnicity in research and
treatment (e.g., Department of Health and Human Services, 2001; Hall, 2001; Sue,
1999).
In an article focusing on ethnicity and science, Sue (1999) argues that the
practice in much psychological research has often been to assume generality of
research findings when it is not warranted. That is, findings from research with a
particular ethnic population are often broadly generalized to other ethnic populations
without the benefit of studies confirming these assumptions. Sue further argues that
because most psychological research is not based on ethnic minority populations,
these assumptions of generality cannot be made, and that more research must be
focused on ethnic minority populations in order to ascertain the extent to which
research findings are universal across populations (Sue, 1999).
In an article focusing on psychotherapy with ethnic minorities, Hall (2001)
states that there is not adequate evidence to support the efficacy of empirically
supported or culturally sensitive treatments with ethnic minorities. Thus, there is a
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need for psychotherapy efficacy research on both empirically supported treatments
(ESTs) and culturally sensitive treatments (CSTs) with ethnic minorities. Because
empirically supported treatments have some empirical basis, Hall (2001) argues that
a good starting point for this research would be to determine the cultural
effectiveness and sensitivity of ESTs before attempting to establish the efficacy of
empirically unsupported culturally sensitive treatments (CSTs). Further, Hall (2001)
suggests that future research should focus on modifying ESTs to be more culturally
sensitive (if necessary), or conversely, should focus on developing empirical support
for existing culturally sensitive treatments.
Lastly, in a supplement to the Mental Health Report of the Surgeon General
(United States Department of Health and Human Services, 2001), it was reported
that although some evidence exists that ethnic minority groups can benefit from
mental health treatment, most of the studies that included ethnic minorities had small
sample sizes and were not randomized clinical trials. There was therefore insufficient
evidence to determine group-specific efficacy of treatment interventions for ethnic
minority populations. To remedy this situation, the report suggests utilizing
randomized controlled trials that include sizeable racial and ethnic minority
populations in order to determine the efficacy of already-proven psychotherapies (or
empirically supported treatments) for ethnic minority groups. The report also states
that further research is essential to determine whether ethnic- or culture-specific
interventions are efficacious for minority populations (U.S. Department of Health
and Human Services, 2001).
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In consideration of the issues mentioned above, the purpose of the present
study was to evaluate the effectiveness of exposure-based cognitive behavioral
therapy in the treatment of Hispanic American youth with anxiety and phobic
disorders relative to Euro-American youth with anxiety and phobic disorders. The
large of percentage of Hispanic Americans who participated in the two Silverman et
al. clinical trials from which this study's data is culled provided a unique opportunity
to examine this issue. However, because this study is based on pre-existing data and
analyses are post hoc, this study should be viewed as exploratory in nature, with it's
purpose being to provide preliminary data to support (or not support) the
effectiveness of exposure-based cognitive behavioral therapy with Hispanic
American youth.
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CHAPTER III
METHODOLOGY
Sample
Data from a total of 131 youths (46% girls) and their parents (1 parent for each
youth participant; 90% mothers) who had participated in one of two randomized
clinical trials for phobic or anxiety disorders (Silverman et al., 1999a, b) were
included in the present set of analyses. All youths were between 6 and 16 years of
age, with an average age of 10.21 years (SD = 2.84). Across the two trials, 79 (60%)
were Euro-American and 52 (40%) were Hispanic American (see Table 2). Across
the two trials there were no statistically significant differences between Euro-
American and Hispanic American participants with respect to the sociodemographic
characteristics shown in Table 2. For Hispanic Americans, 45% of families reported
Cuba as their country of origin, 18% reported other Central and South American
nations as their countries of origin (e.g., Nicaragua, Colombia, Venezuela), and the
remaining Hispanic American f lies reported mixed-Hispanic origin (e.g.,
Colombia + Mexico).
Diagnosis
Anxiety Disorders Interview Schedule for Children (ADIS-C/P; Silverman and
Nelles, 1988). The ADIS-C and ADIS-P were used to derive diagnoses. Previous
research demonstrated satisfactory interrater diagnostic reliability (e.g., K = .84 for
the ADIS-C, K = .83 for ADIS-P, and K = .78 for the composite diagnosis; Silverman
and Nelles, 1988) and test-retest reliability (e.g., 10- to 14-days retest yielded K=
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.76 for the ADIS-C, K = .67 for ADIS-P, and K= .75 for the composite diagnosis;
Silverman and Eisen, 1992). Diagnosticians were trained to use the ADIS-C and
ADIS-P by observing live and videotaped samples. Initial discrepancies were
discussed to reach agreement. Diagnosticians met an initial reliability criterion of
100% agreement on five consecutive child/parent interviews. To determine
diagnoses, separate interviews with the child and parent using the child and parent
versions, respectively, of the ADIS-C were conducted. The clinicians assigned
diagnoses that both sources agreed were most interfering. cases of discordance
between child and parent, the clinician adjusted the severity ratings in considerations
of both sources' views about interference and disturbance, thereby, making final or
"combined" diagnoses a function of both source's reports. In cases of multiple
diagnoses, the relative impact of each specific disorder was determined by
questioning both the child and parent, by obtaining severity ratings from each source,
and by prioritizing each diagnosis/disorder from most interfering or disturbing to
least interfering or disturbing, as delineated in the ADIS-C/P guide (see Albano and
Silverman, 1996). The diagnosis/disorder that was deemed most interfering or
disturbing was rendered the primary diagnosis.
Youth Completed Measures
Revised Children's Maniest Anxiety Scale (RCMAS, Reynolds and Richmond,
1978). The RCMAS is a widely used measure to assess the child's general level of
anxiety. The RCMAS consists of 37 items that describe anxious symptoms to which
the child indicates "yes" or "no." The scale yields three subscales: Worry-
Oversensitivity, Psychological, and Concentration and a Lie subscale. There has
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been extensive work supporting the RCMAS's validity and reliability (see manual,
Reynolds and Richmond, 1985). Pela and Reynolds (1982), for example, reported
excellent test-retest reliability (r=0.98) using a three-week interval.
Fear Survey Schedule for Children-Revised (FSSC-R ; Ollendick, 1983). The
FSSC-R consists of 80 items to which the child rates his or her level of fear ("none,"
"some," or "a lot"). Ollendick reported satisfactory reliability as well as validity for
the FSSC-R.
Parent Completed Measures
R CMAS Parent (RCMAS/P). As has been done by other investigators working
in the child fear/anxiety area (Kendall, 1994; Strauss, Lease, Kazdin, Dulcan, &
Last, 1989), the authors asked parents to rate the occurrence of anxious symptoms in
their children using a parent completed anxiety rating scale. In this study, the stem of
each item on the RCMAS was changed from "I..." to "My child...(e.g., My child
worries about what is going to happen"). The parent responds Yes or No to each
item.
FSSC-R Parent (FSSC-R/P). Parents also completed the FSSC-R inventory
and were asked to rate their children's fears, as in past research (Matson and Love,
1990; Weems, Silverman, Saavedra, Pina, & Lumpkin, 1999). The instructions in the
FSSC-R/P were changed to read "your child's fears" instead of "your fears."
Child Behavior Checklist (CBCL, Achenbach, 1991). This 113-item measure
assesses children's behavioral and social problems and competencies. Each item is
scored on a 0- to 2-point scale ("not true," "somewhat or sometimes true," or "very
true or often true"). The CBCL provides scores for the total scale, as well as for the
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Internalizing and Externalizing subscales. CBCL items, scaled scores, and clinical
cut-points have been found to discriminate between clinic referred and non-referred
children, and normative data are available (Achenbach, 1991)
Procedure
After parents and children signed informed consent and assent, respectively,
assessment measures (i.e., diagnostic interviews and questionnaires) and treatments
were administered at the Child Anxiety and Phobia Program housed within the Child
and Family Psychosocial Research Center, Florida International University, Miami-
Dade. Administration of assessment measures was conducted on two separate
sessions within a 2-week period. In the first session, parents and youths signed
informed consent and assent forms, and were administered the ADIS-C/P and
questionnaires. In the second session, participants completed the remaining
questionnaires. After completing the assessment procedures, participants were
offered an intervention for youths with anxiety disorders and were assigned to
treatment.
All participants were enrolled in one of two time-limited (10 to 12 sessions),
exposure-based psychosocial treatments administered using consistent and similar
experimental procedures (e.g., manualization, trained therapists) at the Child Anxiety
and Phobia Program. The treatments made similar requirements on the clients (e.g.,
completion of forms, in-session assignments, out-of-session assignments) and
18
required similar skill levels on the part of therapists (see Silverman et al. 1999a, b).
After treatment completion, participants were re-administered the interviews and
questionnaires at post-treatment and 3-, 6-, and 12-month follow-up.
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CHAPTER IV
RESULTS
Group Comparability
Chi-square analyses and t-tests revealed no statistically significant
differences between Hispanic American and Euro-American participants in terms of
gender and age; a statistically significant difference was found for family income
with Hispanic Americans reporting lower family incomes than Euro-Americans [
(2) = 27.95,p <.01]. Of the 131 participants, 38 (29%) Hispanic Americans and 62
(47%) Euro-Americans completed treatment; 14 (11%) Hispanic Americans and 17
(13%) Euro-Americans did not complete treatment. There were no significant
differences on any of the socio-demographics or pretreatment youth and parent
completed measures between completers and non-completers. There also were no
statistically significant differences between Hispanic American and Euro-American
youths who completed treatment in terms of gender and age. A statistically
significant difference was found for family income for those who completed
treatment: Hispanic American participants who completed treatment had lower
family income than Euro-Americans participants who completed treatment [ (2)=
18.37,p < .01]. There were no statistically significant differences on any of the
pretreatment youth and parent completed measures between Hispanic American and
Euro-American participants who completed treatment following Bonferroni-based
corrections.
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Treatment Gains
Clinically Significant Change
Chi-square analyses revealed no statistically significant differences between
the proportions of Hispanic American (84.2%) and Euro-American youths (83.9%)
recovered at post-treatment (i.e., no longer met primary diagnoses using the ADIS-
C/P). The CBCL was used to evaluate clinically significant change using normative
comparison (i.e., changes that return clinical scores to the within non-clinical range;
Kendall and Grove, 1988). As done in previous child anxiety clinical trials (e.g.,
Kendall, 1994; Kendall et al., 1997; Silverman, et al., 1999a, b), clinically significant
improvement was defined as meeting a minimum criterion T-score on the CBCL
internalizing scale of less than 70 (adjusted according to age norms). At post-
treatment, 86.4% Hispanic American participants whose initial T-scores were above
70 were within the normative range; 81.8% Euro-American participants whose initial
T-scores were above 70 were within the normative range. Chi-squares showed no
statistically significantly differences between the groups.
Two equivalence intervals around a difference of zero (i.e., ± 10%, + 20%,
with the former being more stringent than the latter; Rogers et al., 1993) were
defined using the outcome for the mainstream (i.e., Euro-American sample) as the
standard, with any difference small enough to fall within the equivalence interval to
be considered of dubious clinical relevance (see Rogers et al.). Equivalence testing
analyses showed that the diagnostic recovery rates at post-treatment for Hispanic
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Americans and Euro-Americans (84.2% and 83.9%, respectively) were statistically
equivalent using the 10% criterion (± 0.84; Lower Confidence Level: -0.13, Upper
Confidence Level: 0.12). The proportions of Hispanic American and Euro-American
youths who showed clinically significant improvement on the CBCL internalizing
scale were not statistically equivalent using the 10% criterion. Use of the 20%
criterion showed a statistically significant equivalent treatment gain between
Hispanic American and Euro-American participants (± 0.16; LCL: -0.14, UCL:
0.05).
Youth and Parent Completed Measures
Means, standard deviations, and within-group effect sizes (Lipsey and
Wilson, 2001) corresponding to the youth and parent completed measures are
presented in Table 3. Significant main effects for time were found for the RCMAS
[F (1, 87)= 17.13, p < .01; eta2 = .17], RCMAS/P [F (1, 92)= 9.05, p< .01; eta2=
.09], FSSC-R/P, F(1, 76) = 6.30, p < .01; eta2 = .07], CBCL internalizing [F (1, 36)
94.88,p < .01; eta = .73], and CBCL externalizing [F (1, 33) = 352.87, p <.01;
eta2 = .91]; no significant timex ethnicity interactions were found for any of these
measures, following Bonferroni based-corrections. Neither pre- nor posttreatment
CBCL externalizing scores were in the clinical range. Mean within group effect sizes
across the youth and parent completed measures were 1.36 (SD = 1.72) for Hispanic
Americans and 1.57 (SD = 1.65) for Euro-Americans.
Table 3 shows the 95% confidence interval, the 10% criterion for
equivalence, and the 90% confidence interval for the post-treatment youth and parent
scores. In terms of statistical equivalency, use of the 10% criterion showed
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equivalency of treatment gains at post-treatment between Hispanic American and
Euro-American youths on the FSSC-R and CBCL internalizing scale. Use of the
20% criterion resulted in statistically significant equivalency at post-treatment
between Hispanic American and Euro-American youths for two additional measures:
the FSSC-R/P (± 1.95; LCL: -0.93, UCL: 0.77) and CBCL externalizing scores (
10.28; LCL: 0.08, UCL: 6.74). No additional statistically significant equivalences
were found.
Treatment Maintenance
Hierarchical linear modeling (HLM; Raundenbush et al., 2001) was used to
test whether the model that best fits the pattern of change exhibited from pre- to
posttreatment, 3-, 6-, and 12-month follow-up was linear (i.e., one of continuous
symptom decline), quadratic (i.e., curvilinear with a single change in direction) or
cubic (i.e., curvilinear with two or more changes in direction). HLM also was used to
evaluate whether differences in these patterns of change varied between Hispanic
Americans and Euro-Americans.
The pattern of change exhibited from pre- to posttreatment, 3-, 6-, and 12-
month follow-up is depicted in Figures 1 and 2 for the youth and parent completed
measures, respectively. Results of the HLM analysis indicated a significant quadratic
component for the RCMAS [x2(50, n 100) 70.97, p <.05], CBCL internalizing
[2(19, n = 99) = 30.57,p < .05], and CBCL externalizing [X 2 (17, n = 98) = 34.5l, p
<.05]. A significant cubic component was found for the RCMAS/P [ 2(54, n = 100)
= 9 2.28,p <.01], FSSC-R [z2 (50, n = 100)= 69.3l, p < .05], and FSSC-R/P [12 (45,
n = 100) = 62.88,p <.05].
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Between-group analyses showed a significant effect for ethnicity on the
quadratic trend for the RCMAS (t ratio = -2.87, p <.01). Euro-American youths
showed more improvement than Hispanic American youths from pre- to
posttreatment, followed by a greater degree of improvement from 6- to 12-month
follow-up for Euro-American youths (see Figure 1). A significant effect for ethnicity
on the cubic trend was found for the FSSC-R (t ratio = 2.36, p < .05). Euro-American
youths showed significantly more improvement from pre- to posttreatment relative to
Hispanic American youths on the FSSC-R. Through the 3- to 6-month follow-up
assessments, Euro-American youths showed a continued decline in fear levels that
resulted in comparable levels to those exhibited by Hispanic American youths at the
12-month follow-up.
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CHAPTER V
DISCUSSION
Because the two Silverman et al. (1999a and b) clinical trials (which
evaluated the efficacy of exposure-based cognitive behavior therapy for reducing
anxiety disorders in youths) contained a substantially higher proportion of Hispanic
American participants than any other published clinical trial, the author was in a
unique position to report treatment effects and maintenance (up to 12 months) for
Hispanic Americans relative to Euro-Americans. Findings showed that Hispanic
American youths responded favorably to cognitive behavior therapy in terms of
treatment gains, and responded similarly to Euro-American youths in terms of
treatment gains. This was evident by a consistent pattem of findings across a variety
of outcome indices: diagnostic recovery rates, clinically significant improvement,
and child and parent completed questionnaires, including average effect sizes.
Statistical equivalence tests (Rogers et al., 1993) provided further support for the
positive findings and for the similarity to Euro-Americans' responses. Specifically,
treatment effects were equivalent for both Hispanic American and Euro-American
youths across diagnostic recovery rates, clinically significant improvement, and child
and parent completed questionnaires. In addition, Hispanic American youths
continued to show favorable treatment response over time in terms of treatment
maintenance. However, there were variations across outcome indices relative to the
Euro-Americans within specific assessment time points (e.g., three to six months
follow up).
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As noted in the Introduction, the samples in Silverman et al. (1999a and b)
are likely to be highly representative of the Hispanic American population in the
United States as they agreed to receive the assessment and intervention procedures
largely in English and they did not request receiving the procedures in Spanish.
Seventy-four percent of Hispanic Americans rate their ability to speak English as
"very well" or "well" (Department of Commerce, 1990). Thus, the study's finding
that an empirically supported intervention approach for use with anxiety disorders in
youth (i.e. exposure- based cognitive behavior therapy) works as well with this
particular segment of Hispanic American youth relative to Euro-American youth
may have considerable importance. This may be especially so given that people of
Hispanic origin are the fastest growing and second largest minority group in the
country (U.S. Bureau of the Census, 2000), and that phobic and anxiety disorders are
the most prevalent psychiatric disorders of youth that do not spontaneously remit
(e.g., Bernstein et al., 1996; Flakierska-Prakin et.al. 1997; Last et. al., 1996;
Woodward and Fergusson, 2001).
As previously mentioned, this study was an exploratory one, and the findings
should be viewed as preliminary in nature and as stepping-stones for future treatment
research aimed at reducing anxiety disorders in Hispanic American youths. Future
research with Hispanic Americans should investigate the potential influence of
variables such as acculturation, biculturalism, and multiculturalism on treatment
gains and maintenance. Results from these types of studies could help pave the way
for the development of empirically informed specialized applications of this
intervention in diverse subsamples of Hispanic youths with anxiety disorder.
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Kurtines and Szapocznik (1996), for example, have described specialized
applications that have targeted the interactions between clinical presentation (e.g.,
conduct disorder symptoms, social maladjustment) and cultural factors (e.g.,
intercultural and intergenerational differences) in the context of immigration and
acculturation stressors.
Limitations
The present findings should be considered in light of the study's limitations. A
main limitation of the present study is the degree to which the findings can be
generalized across Hispanic minority groups. For example, 45% of the Hispanic
American participants in the study were Cuban. It will be important to evaluate
treatment effects and maintenance in samples that contain larger proportions of other
Hispanic American groups. Future studies should include diverse samples of
Hispanic Americans and should examine these issues within groups of Hispanics
(e.g., Cubans compared to Columbians, Nicaraguans, etc.) across their particular
context.
A second limitation is that the treatment sessions were delivered primarily in
English. It will be important in future research to systematically assess the degree to
which therapists and/or clients may have used Spanish on-and-off in session in order
to evaluate the potential influence this may have on treatment effects and
maintenance.
A third limitation is that treatment maintenance was assessed for up to 12
months. As has been done with mainstream samples (Barrett et al., 2001; Kendall
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and Southam-Gerow, 1996) it will be important to evaluate whether gains are
maintained using longer follow-up assessment time intervals.
Clinical Implications
The most important clinical implication of the findings are that Hispanic
American youths responded favorably to cognitive behavior therapy, and similarly to
Euro-American youths, in terms of treatment gains and maintenance. The consistent
pattern of findings that were observed across a variety of outcome indices provides
the clinician with increased confidence that Hispanic American youths responded
positively. Consequently, clinicians should consider using exposure-based cognitive
behavior therapy in treating Hispanic American youths with anxiety disorders.
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TABLE 1
Proportion of Hispanic American Participants in
Child Phobic and Anxiety Clinical Trials
Trial Hispanic Americans
Percentage (0%q)
Kendall (1994) None
Barrett et al. (1996) None
Kendall et al. (1997) 2
Last et al. (1998) 5.4
Cobham et al. (1998) None
Barrett (1998) None
Mendolwitz et al. (1999) None
Silverman et al. (1999a) 37
Silverman et al. (1999b) 46
Beidel et al. (2000) 4
Hayward et al. (2000) None
Spence et al. (2000) None
Shortt et al. (2001) None
Flannery-Schroeder
and Kendall (2000) -
Ginsburg and Drake (2002) None
Note. --- Flannery-Schroeder and Kendall (2001) reported the
proportion (4%) of ethnic-minority participants; proportions of
specific ethnic-minority groups were not reported.
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TABLE 2
Demographic and Diagnostic Information for Hispanic Americans and Euro-
Americans
Hispanic Americans Euro-Americans
(n= 52) (n = 79)
Gender
Boys 29 (55.8%) 35 (44.3%)
Girls 23 (44.2%) 44 (55.7%)
Mean Age 10.21 years 9.51 years
Income
< $21,000 44.4% 14.5%
$ 21,000 to 40,000 33.3% 18.2%
> $ 40,000 22.3% 67.3%
Non-completers 14 17
Primary Diagnosis
GAD/OAD 10(19.2%) 15 (18.9%)
SAD 4 (7.8%) 4 (5.1%)
SOP 10 (19.2%) 7 (8.9%)
SP 23 (44.2%) 46 (58.2%)
Other 5 (9.6%) 7 (8.9%)
Note. GAD/OAD = Generalized Anxiety Disorder/Overanxious Disorder; SAD =
Separation Anxiety Disorder; SOP = Social Phobia; SP = Specific Phobia.
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Figure 1. Mean scores for youth completed measures across pre-
treatment, posttreatment, 3-, 6-, and 12-month follow-up. RCMAS
Revised Children's Manifest Anxiety Scale; FSSC-R = Fear Survey
Schedule for Children-revised.
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Figure 2. Mean scores for parent completed measures across
pretreatment, posttreatment, 3-, 6-, and 12-month follow-up.
RCMAS/P = Revised Children's Manifest Anxiety Scale/Parent
Version; FSSC-R/P = Fear Survey Schedule for Children-
Revised/Parent Version; CBCL = Child Behavior Checklist
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